Pharmaceutical Drug Delivery Market Size, Growth, Share & Trends Analysis

The injectable drug delivery segment held the largest market share in the global pharmaceutical drug delivery market in 2025. A considerable part of the market growth will be contributed from biologics, monoclonal antibodies, vaccines, and other large, molecule therapies that need parenteral administration. Moreover, the escalating global burden of chronic diseases, including cancer, diabetes, autoimmune disorders, and cardiovascular diseases, is boosting the demand for reliable, precise, and efficient dosing solutions, wherein injectables have an added advantage over oral routes. Worldwide, patients and healthcare providers prefer self, administration tools, e.g., autoinjectors, prefilled syringes, pen injectors, and wearable injectors, which facilitate convenience and fewer clinical visits. Importance of safety engineered devices, needle-free injectors, and on-body delivery platforms in this segment can be seen in that these technologies improve adherence, usability, and treatment experience in various healthcare environments.

In the pharmaceutical drug delivery market, by application, injectable drug delivery is expected to be the fastest-growing segment during the forecast period. This segment is driven by the rising prevalence of chronic and complex diseases such as cancer, autoimmune disorders, and metabolic conditions, which increasingly rely on injectable therapies for effective treatment. Injectables enable accurate dosing, faster therapeutic action, and higher bioavailability, making them essential for biologics, vaccines, and advanced therapies including gene and cell treatments. The strong expansion of oncology, immunology, and infectious disease treatments largely dependent on parenteral administration is further accelerating demand across these application areas. Additionally, advancements in drug delivery technologies, such as prefilled syringes, autoinjectors, and long-acting injectables, are improving patient compliance and supporting the shift toward self-administration and home care.

In the pharmaceutical drug delivery marker, the formulations segment—comprising hospitals, ambulatory surgical centers/clinics, home care settings, diagnostic centers, and long-term care facilities—accounted for the largest market share in 2025 and is expected to maintain its dominance during the forecast period. This is because these settings represent the final point of care where drug products are administered to patients, directly driving consumption volumes across all routes of administration. Hospitals hold the largest share within this segment due to their advanced infrastructure, availability of skilled healthcare professionals, and ability to handle complex therapies, such as injectables, biologics, oncology treatments, and critical care medications. The growing burden of chronic diseases, increasing surgical procedures, and rising hospital admissions further strengthen demand in this setting.